📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
151,853
All-time analysed
43,533
Positive
6,742
Negative
92,741
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
92 announcements match the current filters (relevance ≥ 5).
Indian Terrain Q3 FY26: Returns to Profitability with 115% EBITDA Growth to ₹12.76 Cr
Indian Terrain Fashions reported a significant turnaround in Q3 FY26, posting a PAT of ₹2.56 Cr compared to a net loss of ₹3.44 Cr in the same period last year. While revenue grew modestly by 4.66% YoY to ₹101.40 Cr, operational efficiencies led to a massive 115.04% surge in EBITDA. The company successfully expanded its EBITDA margin to 12.58% from 6.12% through better product mix and disciplined cost control. Management highlighted structural improvements in working capital and a strong order book for the upcoming Spring-Summer 2026 season.
Key Highlights
Revenue from operations increased 4.66% YoY to ₹101.40 Cr, sustaining momentum from the previous quarter.
EBITDA more than doubled to ₹12.76 Cr, with margins expanding significantly by 646 bps to 12.58%.
Reported a PAT of ₹2.56 Cr, marking a sharp recovery from a net loss of ₹3.44 Cr in Q3 FY25.
Working capital efficiency improved through TOC-led initiatives, resulting in reduced debtor days and better cash conversion.
Management confirmed a strong SS-26 order book, providing healthy revenue visibility for the upcoming quarters.
👀 What to Watch
The company has successfully transitioned from losses to profitability, indicating that its turnaround strategy and cost-control measures are yielding results. Investors should monitor the sustainability of these expanded margins and the execution of the SS-26 order book in future quarters.
Indian Terrain Returns to Profitability in Q3 FY26 with ₹2.5 Cr PAT; Revenue Grows 4.7% YoY
Indian Terrain Fashions Limited has reported a significant turnaround in Q3 FY26, posting a Profit After Tax (PAT) of ₹2.5 crore after six consecutive quarters of losses. Revenue for the quarter stood at ₹101.4 crore, a 4.7% increase YoY, supported by strong festive demand and a surge in online channel sales. The company's EBITDA grew by 115% YoY to ₹12.8 crore, with margins expanding to 12.58% due to disciplined cost control and store rationalization. Working capital efficiency also improved, with Net Working Capital days reducing to 225 days.
Key Highlights
Turned profitable with a PAT of ₹2.5 crore in Q3 FY26 compared to a loss of ₹3.4 crore in Q3 FY25.
Gross Margin expanded by 393 bps YoY to 43.83% through better channel mix and store optimization.
Online sales surged by ₹8.60 crore YoY, driven by a shift to an outright business model with Flipkart.
Net Working Capital days improved to 225 days from 241 days in March 2025, reflecting tighter credit control.
EBITDA increased 115% YoY to ₹12.8 crore, marking a significant recovery in operating performance.
👀 What to Watch
Investors should view this turnaround positively as the company has successfully exited loss-making formats and improved its margin profile. Monitor the sustainability of this profitability in the coming quarters and the progress of their asset-light expansion through MBOs.
Indian Terrain Returns to Profitability in Q3 FY26 with PAT of ₹2.56 Cr
Indian Terrain Fashions reported a significant turnaround in Q3 FY26, posting a net profit of ₹2.56 crore compared to a net loss of ₹3.44 crore in the same period last year. Revenue from operations grew by 4.6% year-on-year to ₹101.40 crore, while the company successfully reduced total expenses from ₹101.65 crore to ₹97.54 crore. The nine-month performance also showed massive improvement, with losses narrowing to ₹4.01 crore from ₹40.48 crore in the previous year. A one-time exceptional charge of ₹0.58 crore was recorded due to new labor code provisions.
Key Highlights
Net Profit of ₹2.56 crore in Q3 FY26 vs a Net Loss of ₹3.44 crore in Q3 FY25
Revenue from operations increased to ₹101.40 crore from ₹96.88 crore YoY
Total expenses decreased to ₹97.54 crore, aided by lower finance costs of ₹4.69 crore
Nine-month net loss narrowed significantly to ₹4.01 crore from ₹40.48 crore YoY
Exceptional item of ₹0.58 crore recognized for provisions under the New Labour Codes
👀 What to Watch
The company has demonstrated a strong operational turnaround and a return to quarterly profitability. Investors should watch for sustained revenue growth and margin stability in the coming quarters to confirm a long-term recovery trend.
Indian Terrain Q3 Results: Turnaround to Net Profit of ₹2.56 Cr; Revenue Up 4.7% YoY
Indian Terrain Fashions Limited reported a significant turnaround in Q3 FY26, posting a net profit of ₹2.56 crore compared to a net loss of ₹3.44 crore in the same period last year. Revenue from operations grew by 4.7% YoY to ₹101.40 crore, while the company successfully reduced total expenses from ₹101.65 crore to ₹97.54 crore. The 9-month performance also showed drastic improvement, with the net loss narrowing to ₹4.01 crore from a loss of ₹40.48 crore in the previous year. A one-time exceptional charge of ₹0.58 crore was taken for new labor code provisions.
Key Highlights
Revenue from operations rose to ₹101.40 crore in Q3 FY26 from ₹96.88 crore in Q3 FY25.
Net Profit stood at ₹2.56 crore for the quarter, reversing a loss of ₹3.44 crore in the year-ago period.
Finance costs were reduced to ₹4.69 crore from ₹5.47 crore YoY, contributing to improved margins.
9-month net loss narrowed significantly to ₹4.01 crore compared to a loss of ₹40.48 crore in the previous year.
Exceptional item of ₹0.58 crore recognized as a provision for the New Labour Codes (Code on Wages/Social Security).
👀 What to Watch
The company's return to profitability and significant reduction in 9-month losses indicate a successful operational turnaround. Investors should monitor if this margin improvement is sustainable over the next two quarters before considering long-term positions.
Rainbow Children's Medicare Q3 FY26: Revenue Up 12% to ₹445 Cr; New CEO Appointed
Rainbow Children's Medicare reported a 12% YoY revenue growth to ₹445.4 crores for Q3 FY26, while PAT grew 7% to ₹73.9 crores. The company is transitioning from a heavy expansion phase to an execution phase, having recently commissioned hospitals in Rajahmundry and Electronic City. Despite steady operational growth in deliveries (up 16%) and IP discharges (up 9%), occupancy remained at 47.2% due to muted seasonal illnesses. The appointment of Abrarali Dalal as CEO and a strong cash reserve of ₹579 crores position the company for future organic and inorganic growth.
Key Highlights
Revenue grew 12% YoY to ₹445.4 crores; EBITDA increased 9% to ₹147 crores with a 33% margin.
Deliveries saw an impressive 16% YoY growth, while IP discharges and OP volumes rose by 9% and 18% respectively.
Maintains a robust balance sheet with ₹579 crores in cash to fund future CAPEX and M&A through internal accruals.
Commissioned 100-bed Rajahmundry and 90-bed Electronic City units; 60-bed Hennur unit awaiting final approvals.
Successful first pediatric liver transplant in Bengaluru hub, achieving a 94% survival rate across the network.
👀 What to Watch
Investors should monitor the ramp-up of new units and the impact of the new CEO on improving occupancy levels, which currently sit below 50%. The stock remains a solid long-term play on specialized pediatric healthcare given the strong cash position and execution focus.
Rain Industries Subsidiary Joins €1.7M German-Funded Battery Graphite R&D Program
Rain Carbon Germany, a wholly owned subsidiary of Rain Industries, has joined a three-year R&D program titled 'USE-G' to develop sustainable graphite extraction and coating technologies for the European battery industry. The project has a total budget of €1.70 million, with €1.14 million funded by the German Federal Ministry for Economic Affairs and Energy. Rain's specific role is to develop advanced carbon coating materials and sustainable processes to improve battery anode performance. This initiative aims to create a circular economy for lithium-ion batteries and reduce reliance on Chinese supply chains.
Key Highlights
Three-year R&D program (USE-G) launched to run from January 2026 through December 2029.
Total project budget of €1.70 million with €1.14 million in government funding support.
Rain Carbon to develop sustainable carbon coating materials as alternatives to traditional coal tar.
Partnership includes Northern Graphite, H.C. Starck Tungsten, and Friedrich Schiller University Jena.
Focus on recovering graphite from battery black mass and using cleaner purification methods without hydrofluoric acid.
👀 What to Watch
Investors should monitor this as a strategic move to future-proof Rain's product portfolio for the EV battery supply chain. While immediate financial impact is limited, successful R&D could lead to high-margin specialty chemical opportunities by 2030.
Rainbow Children's Medicare Q3 FY26 Revenue Up 21% YoY; OP Consultations Surge 18%
Rainbow Children's Medicare reported a robust 21.2% YoY growth in operating revenue for Q3 FY26, reaching ₹4,057 million. The company witnessed strong volume growth with out-patient consultations increasing by 18% and in-patient discharges by 9%. Expansion remains a key theme, with three new hospitals operationalized in Warangal, Guwahati, and Rajahmundry during the fiscal year. While EBITDA grew 14.3% to ₹1,313 million, overall occupancy moderated to 47.2% due to the significant addition of new capacity beds.
Key Highlights
Operating Revenue increased 21.2% YoY to ₹4,057 million in Q3 FY26.
EBITDA stood at ₹1,313 million, up 14.3% YoY, with a margin of 32.4%.
Out-patient consultations grew 18% YoY to 4,17,342; In-patient discharges rose 9% to 27,977.
ARPOB (Average Revenue Per Occupied Bed) improved by 9% YoY to ₹58,362.
Total capacity beds reached 2,285 following the addition of hospitals in Warangal, Guwahati, and Rajahmundry.
👀 What to Watch
Investors should monitor the occupancy levels and margin stabilization as the newly added hospitals move through their gestation periods. The strong growth in OP consultations and ARPOB suggests healthy underlying demand for specialized pediatric services.
Rainbow Children’s Q3 Revenue Up 11.9% YoY to ₹445 Cr; Focus Shifts to Execution
Rainbow Children’s Medicare reported a steady Q3 FY26 with revenue growing 11.9% YoY to ₹4,454 Mn and PAT increasing 7.2% to ₹739 Mn. While operational capacity expanded by 18% to 2,285 beds, occupancy rates dipped to 47.19% from 53.20% YoY due to the rapid addition of new units in Rajahmundry and Bengaluru. The company has largely completed its current expansion cycle and is now focusing on operational excellence and ramping up occupancy in new facilities. A strong cash position of ₹5,792 Mn supports future growth and ongoing projects in Gurugram and Pune without external debt.
Key Highlights
Revenue grew 11.9% YoY to ₹4,454 Mn, while EBITDA margins remained healthy at 33.0%.
Operational beds increased by 15% to 1,758, though occupancy fell 601 bps to 47.19% due to new capacity additions.
ARPOB (Average Revenue Per Occupied Bed) improved by 9% YoY to ₹58,362.
Commissioned two new hospitals in Rajahmundry (100 beds) and Electronic City, Bengaluru (90 beds).
Maintains a robust cash and investment balance of ₹5,792 Mn as of December 31, 2025.
👀 What to Watch
Investors should monitor the occupancy ramp-up in newly commissioned units, as the shift from expansion to execution is expected to drive margin improvement. The company's ability to fund large-scale expansions in NCR and Pune through internal accruals remains a significant long-term positive.
Rainbow Children's Medicare Q3 Standalone PAT at ₹658.2 Mn, Revenue Up 3.4% YoY
Rainbow Children's Medicare reported a standalone revenue of ₹3,943.52 million for Q3 FY26, a 3.4% increase over ₹3,815.65 million in Q3 FY25. Standalone Profit After Tax (PAT) declined slightly by 1.7% YoY to ₹658.24 million, down from ₹669.75 million. Sequentially, the performance was lower than Q2 FY26, where revenue was ₹4,084.96 million and PAT was ₹731.67 million. The board also confirmed the appointment of Mr. Abrarali Dalal as CEO starting January 2026.
Key Highlights
Standalone Revenue from operations grew 3.35% YoY to ₹3,943.52 million
Standalone Profit After Tax (PAT) decreased by 1.7% YoY to ₹658.24 million
Total expenses rose to ₹3,166.74 million from ₹3,023.00 million in the previous year's quarter
Basic EPS for the quarter stood at ₹6.48 compared to ₹6.60 in Q3 FY25
Mr. Abrarali Dalal officially took charge as the Chief Executive Officer (CEO) on January 20, 2026
👀 What to Watch
The results indicate a period of consolidation with flat YoY profit growth and a sequential dip in margins. Investors should monitor the new CEO's impact on operational efficiency and the company's expansion strategy in the specialized pediatric healthcare market.
Bohra Industries: Mark AB Capital Becomes Promoter; Krishna Agarwal Reclassified to Public
Bohra Industries has announced a formal change in its promoter structure following the completion of an open offer by Mark AB Capital Private Limited. Krishna Agarwal, holding 10,98,239 shares (4.73% stake), has been reclassified from the 'Promoter' category to 'Public' category. Mark AB Capital is now officially recognized as the new promoter of the company. This transition follows the open offer completed on August 13, 2025, and adheres to SEBI's regulatory requirements for reclassification.
Key Highlights
Mark AB Capital Private Limited is now the official Promoter of Bohra Industries following an Open Offer.
Krishna Agarwal reclassified to Public category with a 4.73% stake (10,98,239 shares).
The reclassification is effective immediately as per SEBI Regulation 31A(10).
The outgoing promoter will have no board representation or KMP roles for at least three years.
Company confirms compliance with Minimum Public Shareholding (MPS) requirements.
👀 What to Watch
Investors should monitor the new promoter's strategic plans and any potential changes in the company's operational management. The formalization of this leadership shift may lead to new growth initiatives or structural changes.
Rainbow Children's Medicare Launches 90-Bed Hospital in Bengaluru; Total Capacity at 2,375 Beds
Rainbow Children’s Medicare Limited (RCML) has inaugurated a new 90-bed spoke hospital in Electronic City, Bengaluru, increasing its total capacity to approximately 2,375 beds. The project, costing approximately ₹55 crore, was funded entirely through internal accruals, demonstrating strong cash flow management. This facility marks the company's fifth hospital in Bengaluru and will operate under the hub-and-spoke model linked to the Marathahalli hub. This expansion targets a high-growth corridor with a young population, enhancing the company's footprint in a key focus market.
Key Highlights
New 90-bed spoke hospital launched in Electronic City, Bengaluru, increasing total capacity to ~2,375 beds.
Total project investment of approximately ₹55 crore financed through internal accruals.
Strengthens the hub-and-spoke model in Bengaluru, serving as a spoke to the Marathahalli hub.
Company occupancy stood at 46.3% in Q2 FY 2025-26 prior to this addition.
The facility offers comprehensive pediatric and perinatal services, including neonatal and pediatric intensive care.
👀 What to Watch
The expansion is a positive indicator of the company's growth strategy and ability to scale using internal funds. Investors should monitor the occupancy ramp-up at the new facility to assess its impact on future earnings.
Cerebra Integrated Receives E-Auction Sale Notice from Canara Bank under SARFAESI Act
Cerebra Integrated Technologies Limited has received an e-auction sale notice from Canara Bank, a secured lender, on January 23, 2026. This action, taken under Section 13(4) of the SARFAESI Act, 2002, follows a previous disclosure regarding debt issues dated July 15, 2025. The notice indicates that the bank is proceeding with the sale of secured assets to recover outstanding dues. This development highlights severe financial distress and the risk of asset liquidation for the company.
Key Highlights
Received e-auction sale notice from Canara Bank on January 23, 2026
Action initiated under Section 13(4) of the SARFAESI Act for recovery of secured debts
Follow-up to a previous regulatory intimation made on July 15, 2025
Indicates a failure to resolve defaults with the secured lender leading to asset enforcement
👀 What to Watch
Investors should exercise extreme caution as the company faces asset seizure and liquidation by lenders. The enforcement of the SARFAESI Act suggests a high risk of insolvency or significant operational disruption.
